HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYN

Conferences

Benjamin L. Schlechter, MD, on TAC01-HER2 in HER2-Positive Solid Tumors

November 1st 2022

Schlechter discussed the potential advantages of TAC01-HER2 over current standards of care.

Benjamin L. Schlechter, MD, on Addressing Unmet Needs in HER2 Positive Solid Tumors

October 31st 2022

Schlechter discussed the design of the TACTIC-2 clinical trial for patients with HER2-positive solid tumors.

Deyaa Adib, MD, on Optimizing Manufacturing of Solid Tumor Cell Therapies

October 13th 2022

The chief medical officer of Triumvira Immunologics discussed the company’s future plans.

Deyaa Adib, MD, on Safety Advantages of TAC T-Cell Therapy in Solid Tumors

September 26th 2022

The chief medical officer of Triumvira Immunologics discussed how TAC01-HER2 could address unmet needs in treating solid tumors.

Jeffrey Miller, MD, on Emerging Research With Natural Killer Cells

September 24th 2022

The deputy director of the Masonic Cancer Center discussed trends of presentations from ESMO 2022.

Deyaa Adib, MD, on Evaluating HER2 TAC T-Cell Therapy in Solid Tumors

September 22nd 2022

The chief medical officer of Triumvira Immunologics discussed updates from the TACTIC-2 study presented at ESMO Congress 2022.

Jeffrey Miller, MD, on Engaging NK Cells in Solid Tumors

September 20th 2022

The deputy director of the Masonic Cancer Center discussed the preclinical findings of his study on a TriKE engager and NK cells.

David S. Hong, MD, on the SURPASS Clinical Trial and TCR T-cell Therapy in Solid Tumors

September 19th 2022

Hong presented data from the SURPASS clinical trial at the 2022 European Society for Medical Oncology (ESMO) Congress.

Weijia Fang, MD, and Guoqiang Ai, MD, on the Future of IMC001 in Gastric and Colorectal Cancer

September 17th 2022

Fang commented on a limitation of the clinical trial pointed out at the European Society for Medical Oncology (ESMO) 2022 Congress.

Weijia Fang, MD, and Tianhang Luo, MD, on EpCAM-Targeted CAR-T Therapy in Advanced Colorectal and Gastric Cancer

September 13th 2022

Fang recently presented at the European Society for Medical Oncology (ESMO) 2022 Congress.